Abstract
A series of negative clinical trials of disease-modifying agents for Alzheimer’s disease has increased pessimism regarding the prospects for important therapeutic advances. But limited efficacy may be attributed in part to the advanced degree of neurodegeneration present at the onset of dementia. To optimize the likelihood of success, it is essential to develop the methodology to allow testing of disease-modifying treatments at an early stage of pathology, when modulation of pathophysiologic mechanisms may yield major clinical benefits.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Schneider LS. The Potential and Limits for Clinical Trials for Early Alzheimer’s Disease and Some Recommendations. J Nutr Health Aging. 2010;14(4):295–298.
Doody RS. Evolving Early (Pre-Dementia) Alzheimer’s Disease Trials: Suit the Outcomes to the Population and Study Design. J Nutr Health Aging. 2010;14(4):299–302.
Petersen RC. Clinical Trials for Early (Pre-Dementia) Alzheimer’s Disease: A Case for Mild Cognitive Impairment. J Nutr Health Aging. 2010;14(4):304–305
Cedarbaum JM, Crans G, Grundman M. Seeing with New Eyes: Finding a Path to Early Intervention Trials in Alzheimer’s Disease. J Nutr Health Aging. 2010;14(4):306–309.
Potter WZ. Dose Ranging for Trials through Biomarkers of Drug Effects. J Nutr Health Aging. 2010;14(4):310–311.
Schindler RJ. Study Design Considerations: Conducting Global Clinical Trials in Early Alzheimer’s Disease. J Nutr Health Aging. 2010;14(4):312–314.
Richard E, Ligthart SA, Moll van Charante EP, Van Gool WA. Methodological issues in a cluster-randomized trial to prevent dementia by intensive vascular care. J Nutr Health Aging. 2010; 14(4):315–317
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aisen, P.S. Pre-dementia Alzheimer’s trials: Overview. J Nutr Health Aging 14, 294 (2010). https://doi.org/10.1007/s12603-010-0065-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-010-0065-2